Lexicon Pharma (LXRX) Tops Q3 EPS by 7c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Lexicon Pharma (LXRX) Tops Q3 EPS by 7c, Revenues Miss

Lexicon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides a Business Update

November 1, 2018 7:00 AM EDT

THE WOODLANDS, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended September 30, 2018.

In the third quarter, we and our collaborator, Sanofi, have been working diligently with regulatory agencies to make sotagliflozin available for patients with type 1 diabetes as quickly as possible and... More